Kopran Stock Screener | Share Price & Fundamental Analysis

KOPRAN Pharmaceuticals
Share Price NSE
₹146.27
▲ 11.95 (8.90%)
2026-04-08 00:00:00
Share Price BSE
₹146.15
▲ 11.60 (8.62%)
2026-04-08 00:00:00
Track Kopran share price live with TickJournal's free stock screener. Analyze Kopran share price history trends and compare 52-week high low levels. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Kopran Market Cap ₹579.35 Cr.
KOPRAN P/E Ratio (TTM) 34.56
Kopran P/B Ratio 1.14
EPS (TTM) ₹7.99
Dividend Yield 2.53%
Debt to Equity 0.24
KOPRAN 52 Week High ₹205.85
Kopran 52 Week Low ₹108.04
Operating Margin 10.00%
Profit Margin 5.68%
KOPRAN Revenue (TTM) ₹176.00
EBITDA ₹20.00
Net Income ₹10.00
Total Assets ₹844.00
Total Equity ₹518.00

Kopran Share Price History - Stock Screener Chart

Screen KOPRAN historical share price movements with interactive charts. Analyze price trends and patterns.

Kopran Company Profile - Fundamental Screener

Screen Kopran company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for KOPRAN shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE082A01010

Kopran Balance Sheet Screener

Screen KOPRAN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Assets
Total Assets 844 743 650 611 439 371 352 316 298 264
Current Assets 510 454 399 415 277 223 208 194 180 154
Fixed Assets 208 182 165 151 112 111 113 104 105 101
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 37 34 34 33 34 42 49 35 37 33
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 518 491 439 426 245 190 169 145 125 109
Share Capital 48 48 48 48 43 43 43 43 43 52
Reserves & Surplus 470 443 391 378 202 146 125 102 81 57

Kopran Income Statement Screener - Profit & Revenue Analysis

Screen Kopran income statement and profit fundamentals. Analyze KOPRAN quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Kopran share price evaluation.
Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar 2022-Jun 2022-Sept
Revenue 176 138 118 194 196 142 153 166 153 119 153 161 145 126 117
Expenses 155 121 123 177 164 121 137 146 137 111 130 135 117 113 107
EBITDA 20 17 -5 18 31 21 16 20 16 9 23 26 28 14 11
Operating Profit % 10.00% 10.00% -4.00% 9.00% 12.00% 13.00% 10.00% 12.00% 8.00% 5.00% 15.00% 15.00% 18.00% 10.00% 9.00%
Depreciation 4 4 4 4 4 4 4 4 3 3 3 3 3 3 3
Interest 3 3 2 3 3 2 2 2 2 2 2 2 1 1 1
Profit Before Tax 14 10 -12 11 25 15 10 14 11 4 18 21 24 10 6
Tax 4 2 -2 1 7 4 2 4 3 1 5 5 7 2 1
Net Profit 10 7 -10 9 19 11 7 10 8 3 14 16 18 8 5
EPS 2.01 1.54 -2.06 1.93 3.86 2.30 1.53 2.16 1.67 0.58 2.86 3.28 3.68 1.58 0.97

Kopran Cash Flow Screener - Liquidity Fundamentals

Screen KOPRAN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities 42 43 34 -34 60 31 25 26 16 29
Investing Activities -56 -44 -13 -84 -25 -13 -25 -11 -18 -9
Financing Activities 26 1 -20 123 -35 -18 -1 -15 2 -19
Net Cash Flow 11 1 2 5 0 0 0 0 0 0

Kopran Shareholding Pattern Screener

See Kopran shareholding pattern with promoter, FII, and DII holdings. Check Kopran promoter holding and ownership changes for KOPRAN on TickJournal.
Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec
Promoter Holding 44.42% 44.42% 44.42% 44.42% 44.49% 44.49% 44.49% 44.46%
FII Holding 1.12% 0.76% 0.60% 0.36% 0.84% 0.68% 1.32% 0.86%
DII Holding 0.00% 0.00% 0.00% 0.00% 1.20% 0.14% 0.22% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 41.36% 42.83% 44.65% 44.71% 37.98% 39.69% 40.74% 41.35%
Other Holding 13.10% 11.99% 10.33% 10.51% 15.49% 15.01% 13.23% 13.32%
Shareholder Count 58,652 60,194 62,222 60,886 50,850 51,492 57,154 60,560

Kopran Share Dividend Screener - Share Yield Analysis

Check Kopran dividend history with payout and yield data. View Kopran dividend details including ex-dates and amounts for KOPRAN stock.
Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹3.00 2.78%
2024-March ₹3.00 1.71%
2023-March ₹3.00 1.16%
2022-March ₹3.00 2.97%
2021-March ₹3.00 1.07%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Kopran Stock Index Membership

See which indices include Kopran stock. Check KOPRAN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE INDEX BSE HC
BSE INDEX SMLCAP

Kopran Market Events Screener - Corporate Actions

Get Kopran corporate actions including splits, bonuses, and buybacks. Check Kopran stock events that may affect KOPRAN share price.
Announcement Date Record Date Event Type Information Price Impact
Dividend ₹ 3.00 /share -10.35%
Dividend ₹ 3.00 /share 66.33%
Dividend ₹ 3.00 /share 18.17%
Annual General Meeting NA 26.71%
Annual General Meeting NA 2.79%
2026-01-22 2026-01-22 Quarterly Result Announcement NA -8.41%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -4.13%
2025-07-29 2025-07-29 Quarterly Result Announcement NA -1.94%
2025-05-15 2025-05-15 Quarterly Result Announcement NA 7.28%
2025-02-11 2025-02-11 Quarterly Result Announcement NA -0.98%
2024-11-13 2024-11-13 Quarterly Result Announcement NA 0.67%
2022-08-04 2022-08-08 Dividend ₹ 3.00 /share -10.27%
2021-08-05 2021-08-09 Dividend ₹ 1.50 /share 6.33%

Kopran Competitors Screener - Peer Comparison

Screen KOPRAN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 406,351 37.86 54,729 9.71% 10,980 37.98
Divis Laboratories 155,472 63.26 9,712 18.67% 2,191 33.24
Torrent Pharmaceuticals 134,945 61.20 11,539 6.99% 1,911 32.75
Lupin 103,954 22.26 22,910 13.74% 3,306 47.35
Dr Reddys Laboratories 101,601 18.27 33,741 16.73% 5,725 39.36
Cipla 96,320 21.31 28,410 7.12% 5,291 26.86
Zydus Life Science 86,964 17.29 23,511 18.55% 4,615 41.42
Mankind Pharma 82,499 45.81 12,744 20.90% 2,007 41.40
Aurobindo Pharma 77,462 22.37 32,346 9.43% 3,484 64.38
Alkem Laboratories 62,867 25.87 13,458 3.70% 2,216 42.54

Kopran Company Announcements - News Screener

Screen KOPRAN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-03-24 Closure of Trading Window -
2026-03-17 Announcement under Regulation 30 (LODR)-Resignation of Director -
2026-02-28 Announcement under Regulation 30 (LODR)-Scheme of Arrangement -
2026-02-27 Announcement under Regulation 30 (LODR)-Scheme of Arrangement -
2026-02-20 Cyber-Attack At Khopoli Factory -
2026-01-23 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-01-23 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-01-22 Board Meeting Outcome for Results For Q3 FY 2025-26 -
2026-01-21 Announcement Under Regulation 30 (LODR) -
2026-01-13 Board Meeting Intimation for Results Of Q3 FY 2025-26 -
2026-01-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-01-01 Announcement under Regulation 30 (LODR)-Credit Rating -
2025-12-26 Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2025-12-23 Closure of Trading Window -
2025-12-02 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2025-11-12 Announcement under Regulation 30 (LODR)-Investor Presentation -
2025-11-12 Announcement under Regulation 30 (LODR)-Investor Presentation -
2025-11-12 Board Meeting Outcome for Outcome Of Board Meeting -
2025-10-30 Board Meeting Intimation for Financial Result Q2 FY 2025-26 -
2025-10-10 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -